Literature DB >> 26544791

Phenotypic Change and Induction of Cytokeratin Expression During In Vitro Culture of Corneal Stromal Cells.

Laura E Sidney, Owen D McIntosh, Andrew Hopkinson.   

Abstract

PURPOSE: Cells of the corneal epithelium and stroma can be distinguished in vivo by different intermediate filaments, cytokeratins for corneal epithelial cells (CEC) and vimentin for keratocytes. Isolated and cultured keratocytes change phenotype, losing expression of keratocyte markers and gaining markers associated with mesenchymal stromal cells (MSC). This study investigates this change in phenotype in relation to intermediate filament expression in cultured corneal stromal cells (CSC) compared to CEC.
METHODS: Expression of epithelial markers (CK3, CK12, CK19, pan cytokeratin, E-cadherin), keratocyte markers (CD34, vimentin), and MSC markers (CD73, CD90, and CD105) were compared in CEC and CSC by immunocytochemistry and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Expression was evaluated at different stages of CSC culture and compared to another stromal cell type, extracted from Wharton's jelly (WJ-MSC).
RESULTS: In vivo keratocytes did not express cytokeratins. However, cultured CSC expressed epithelial-associated CK3, CK12, and CK19, but not other cytokeratins. Expression of cytokeratins increased as CSC were passaged and decreased as CSC were induced to become quiescent. Comparatively, WJ-MSC expressed lower levels of CK3, CK12, and CK19, but also stained for pan cytokeratin and expressed KRT5.
CONCLUSIONS: Cultured CSC undergo phenotypic change during culture, expressing specific cytokeratin filaments normally associated with CEC. Cytokeratin expression begins as cells are cultured on plastic and increases with passage. This discovery may influence the way in which differences are discerned between cultured CEC and CSC. Investigators need to be aware that the expression of cytokeratins does not necessarily represent epithelial contamination, and that CEC and CSC may be more related than previously recognized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26544791     DOI: 10.1167/iovs.15-17810

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination.

Authors:  Henrike Julich-Haertel; Marina Tiwari; Christina Mehrfeld; Elmar Krause; Miroslaw Kornek; Veronika Lukacs-Kornek
Journal:  J Vis Exp       Date:  2017-02-18       Impact factor: 1.355

2.  Molecular markers for corneal epithelial cells in larval vs. adult Xenopus frogs.

Authors:  Surabhi Sonam; Jennifer A Srnak; Kimberly J Perry; Jonathan J Henry
Journal:  Exp Eye Res       Date:  2019-04-11       Impact factor: 3.467

3.  Postnatal periodontal ligament as a novel adult stem cell source for regenerative corneal cell therapy.

Authors:  Gary Hin-Fai Yam; Ericia Pei-Wen Teo; Melina Setiawan; Matthew J Lovatt; Nur Zahirah Binte M Yusoff; Matthias Fuest; Bee-Tin Goh; Jodhbir S Mehta
Journal:  J Cell Mol Med       Date:  2018-03-13       Impact factor: 5.310

4.  Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers.

Authors:  Swapnil C Kamble; Arijit Sen; Rahul D Dhake; Aparna N Joshi; Divya Midha; Sharmila A Bapat
Journal:  J Clin Med       Date:  2019-03-08       Impact factor: 4.241

5.  Anti-inflammatory potential of human corneal stroma-derived stem cells determined by a novel in vitro corneal epithelial injury model.

Authors:  Mariana Lizeth Orozco Morales; Nagi M Marsit; Owen D McIntosh; Andrew Hopkinson; Laura E Sidney
Journal:  World J Stem Cells       Date:  2019-02-26       Impact factor: 5.326

6.  Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing.

Authors:  Zoltán Veréb; Szilárd Póliska; Réka Albert; Ole Kristoffer Olstad; Anita Boratkó; Csilla Csortos; Morten C Moe; Andrea Facskó; Goran Petrovski
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

Review 7.  Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders.

Authors:  Lydia J Beeken; Darren S J Ting; Laura E Sidney
Journal:  Stem Cells Transl Med       Date:  2020-09-08       Impact factor: 6.940

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.